| 000 | 01833 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513174722.0 | ||
| 264 | 0 | _c19990524 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1006/bbrc.1999.0472 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBelfi, C A | |
| 245 | 0 | 0 |
_aIncreased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cApr 1999 |
||
| 300 |
_a361-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a6-Aminonicotinamide _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCarmustine _xpharmacology |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 |
_aColonic Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aCross-Linking Reagents _xpharmacology |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEndoplasmic Reticulum Chaperone BiP |
| 650 | 0 | 4 | _aHeat-Shock Proteins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelphalan _xpharmacology |
| 650 | 0 | 4 |
_aMolecular Chaperones _xgenetics |
| 650 | 0 | 4 |
_aNAD _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPoly Adenosine Diphosphate Ribose _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aChatterjee, S | |
| 700 | 1 | _aGosky, D M | |
| 700 | 1 | _aBerger, S J | |
| 700 | 1 | _aBerger, N A | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 257 _gno. 2 _gp. 361-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.1999.0472 _zAvailable from publisher's website |
| 999 |
_c10157612 _d10157612 |
||